In the second round of presentations held at the end of August, 10 startups lined up to make presentations, and three were selected as a result. A total of 40 Taisho Pharmaceutical employees from 13 departments were involved in the brush-up process.
What is Taisho's open innovation project like as depicted with the three selected startups?

Quantum Operation x Taisho Pharmaceutical
By combining Quantum Operation's sensor development technology and know-how with Taisho Pharmaceutical's broad sales channels, the company aims to establish a personalized health management system and realize its penetration.

Quantum Operation is an IT vendor specializing in the development of IoMT (Internet of Medical Things) sensors. Quantum Operation unites a number of overseas companies in Shenzhen, China, which is said to surpass Silicon Valley in the world, and supplies sensors and platforms on an OEM basis to companies that wish to outsource their manufacturing. By controlling the "Shenzhen supply chain" and conducting production and quality control, the company is able to develop products of high quality at a lower cost than usual. Currently, the company is developing a next-generation vital band that can measure blood glucose levels and other parameters as its own product using these manufacturing platforms.
https://creww.me/ja/startup/quantum-op
Erie x Taisho Pharmaceutical
The goal is to "develop new markets and contribute to the SDGs" by combining Ellie's research expertise in silkworms and edgy products with Taisho Pharmaceutical's broad sales channels including overseas, product development and marketing capabilities, and research and development infrastructure. and contribution to the SDGs" by combining Taisho Pharmaceutical's extensive sales channels, product development and marketing capabilities, and research and development infrastructure, including overseas.

It is predicted that the world population will reach approximately 9 billion in 2030, and that approximately 600 million people will be protein deficient due to constraints on global resources. Insects are a promising alternative protein, but it is difficult to imagine that they will become popular in Japan, a country with an insatiable appetite. In order to foster an entomophagy culture in Japan, Erie is developing and marketing insect foods with the hope of creating a market by promoting the functional ingredients of insects and expanding its brand of Japanese food x functional entomophagy to the rest of the world.
https://creww.me/ja/startup/Ellie
Minacara x Taisho Pharmaceutical
By combining Minacara's online medical services with Taisho Pharmaceutical's product capabilities and sales channels, the company aims to realize "OTC purchase support by online pharmacists".
Minakara leverages pharmacists and dispensaries to provide online servicesonline pharmacyThe first is.

https://creww.me/ja/startup/minacolor.inc
The above co-creation projects with three startups have been decided, and demonstration experiments are currently underway.
The pharmaceutical industry has entered a period of change due to deregulation and drug price issues. Taisho Pharmaceutical is in the midst of a period of change in the industry,Behavioral habits and culture of trying new thingsThe Accelerator Program is one such initiative. The Accelerator Program is one such initiative.
We look forward to the chemical reactions that will be created by the involvement of many departments with startups that have a different culture from that of legacy companies.
PORT Editorial Office PORT" is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies aiming to create new businesses on the theme of social issues, operated by Creww, Inc.








